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Vanadium compounds have been believed to be 
ideal drugs for diabetes biological therapy in future, 
but they suffer setback for the potential toxicity now. 
Toxicity study is necessary for vanadyl drugs 
development. This paper investigated the toxicity 
effects of vanadyl sulfate (VOSO4) oral administration 
in male Wistar rats using 1H NMR-based metabonomic 
analysis and clinical biochemical analysis. Rat urine 
were collected and their 1H NMR spectra were 
acquired, and then subjected to multi-variable 
statistical analysis. Compared to control groups, 
urinary excretion of lactate, TMAO, creatinine, taurine 
and hippurate increased following VOSO4 dosing, with 
concomitant decrease in the level of acetate and 
succinate. The dosed groups can be readily 
discriminated from the control groups by principle 
component analysis. The results showed that VOSO4 
can affect energy metabolism process, interrupted 
intestinal microfloral metabolism, and induced liver 
and kidney injury. NMR-based metabonomic can offer 
additional information to traditional clinical chemistry 




The anti-diabetic effects of vanadium compounds, 
such as vanadyl sulfate (VOSO4), are well-documented 
in both type 1 and type 2 diabetes in the past decades 
[1]. Unfortunately, the potential toxicity has been the 
major problem of vanadium treatment of diabetic 
animals. Vanadium salts may cause the decrease of 
food intaking, diarrhea and weight loss. Hematological 
and biochemical changes, reproductive and 
developmental toxicity, hepatotoxicity, nephrotoxicity, 
as well as a number of miscellaneous toxic effects have 
been also found in healthy rats and mice following 
vanadium exposure[1]. However, their toxic 
mechanism, especially the changes in metabolic 
profiling, is unclear. 
Biochemical items detection is a conventional 
method for the toxicological analysis. But the 
conventional biochemical method is limited since only 
a small number of endogenous markers or key 
enzymes can be monitored routinely. Recently, NMR-
based metabonomics has brought a new systematic 
analysis method to identify the site and possible 
mechanism of toxicity and offered much information 
of endogenous metabolites and their variation in 
pathological states [2]. The biochemical composition 
of biofluids, such as urine and serum, reflects the 
toxin- or disease-induced changes of organism. NMR 
spectroscopy of biofluids can present comprehensive 
biochemical profiles of low-molecular-weight 
metabolites reflecting the biochemical elects caused by 
xenobiotics. And then, through pattern recognition to 
classify NMR-derived data and multivariate statistical 
analysis methods, much information of endogenous 
metabolites and their variation in pathological states 
can be obtained. NMR-based metabonomics 
technology in biofluids has shown strong potential to 
the identification of biomarkers of toxicity and disease, 
monitoring sequential metabolic perturbations in 
biofluids and tissues following toxic insult [3,4,5,6]. 
In this study, VOSO4, as an example of inorganic 
vanadium compounds, was investigated for the acute 
biochemical profiles in urine to further understand the 
biochemical effects of VOSO4 using NMR-based 
metabonomic approaches. Significant changes of 
urinary metabolites were observed, which indicated 
that VOSO4 treatment affected energy metabolism 
process, interrupted intestinal microfloral metabolism, 
and induced liver and kidney injury. 
 
2. Materials and methods 
 
2.1. Animal handling and sample collecting 
 
VOSO4 were purchased from Sigma company. Male 
Wistar rats were bred in the animal room of the 
Xiamen University Medical College Laboratory 
Animal Center (temperature: 25 ± 3°C; humidity: 50 ± 
10%, 12 h light/12 h dark cycle). Fifteen Male Wistar 
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rats (weighing 200 ~ 250g) were divided into three 
groups (nD5) and housed individually in metabolism 
cages which allowed free access to food and water 
under controlled conditions. Each rat received an oral 
dose of either VOSO4 (15mg/kg body weight), VOSO4 
(30 mg/kg body weight), or saline (0.9%, 10ml/ kg 
body weight). After 16 days, urine samples were 
collected overnight (24 h) in metabolism cages at 
ambient temperature. Then samples collected were 
stored frozen at -20°C until NMR analysis. For each 
blood sample, serum was obtained by centrifugation 
(3000 rpm, 15 min), and was retained frozen at −80°C 
until clinical chemistry analysis. One part of each liver 
and kidney samples was fixed in 10% formalin for 
histopathological assessment. 
 
2.2. Clinical chemistry and histopathology 
 
Serum samples were characterized on HITACHI 
7170 analyzer to obtain clinical chemical parameters: 
blood urea nitrogen (Urea), creatinine (CRE), alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), alkaline phosphatase (ALP), total protein (TP), 
albumin (ALB), and uric acid (UA). Histological 
sections of VOSO4-treated and control rats were 
prepared and stained with hematoxylin and eosin (H 
and E) and examined by light microscopy. 
 
2.3. 1H NMR spectroscopy of urine samples 
 
200 microlitres of phosphate buffer (0.2M 
Na2HPO4/0.2M NaH2PO4, pH7.0, 100% D2O) was 
added into 400 microlitres urine samples to minimize 
variations in the pH of the urine samples. 0.3mM DSS 
was used as an internal reference standard (d 0.00). 
The mixture was pipetted into 5 mm NMR tubes. 1H 
NMR spectra were recorded on Varian Unity plus 500 
MHz at 300K. Water signals were suppressed by 
presaturation pulse sequence. 128 FIDs were collected 
into 8K data points with relaxation delay 5s and flip 
angle 90 degree. The spectral width was 5 KHz. 
 
2.4. Data preprocessing 
 
All NMR spectra were phased, baseline corrected 
and integrated into region of 0.04 ppm width in the 
region of 0.5 ~ 9.5 ppm. The region of 4.5 ~ 5.0 ppm 
in the urine and serum spectra for all groups was 
excluded prior to pattern recognition analysis to refrain 
from the variation in water suppression efficiency. For 
urine spectra, the region containing urea (5.2 ~ 6.0 
ppm) was also excluded to eliminate any cross-
relaxation effects on the urea signal. The remaining 
spectral segments were scaled to total integrated area 
of each spectrum. The data set was mean-centered 
prior to principal components analysis (PCA). The 
NMR spectral processing, PCA of NMR data were 
performed using in house software. 
 
Fig.1 1H NMR spectra of urine of control and VOSO4-
dosed rats. (a) control rat; (b) dosage of 15 mg/kg; (c) 
dosage of 45 mg/kg. 
3. Results and discussion 
 
3.1. Spectral analysis of rat urine samples 
 
A typical 1H NMR spectra of urine sample of three 
groups were illustrated in Fig.1. The assignments of 
important metabolites in urine samples are presented in 
Table1. A number of alterations were identified in 
urine samples of VOSO4-fed groups compared to 
control group, with a dose-dependent variability. 
Following VOSO4 dosing, there were increases in 
alanine, TMAO, taurine, creatinine, DMA, DMG, 
glycine, urea, hippurate, phenylalanine and lactate, 
together with decreases in succinate, acetate. 1H NMR 
urinalysis identified a rise in creatine and taurine. 
These are well-known urinary biomarkers of liver 
injury [7], and this pattern of changes in creatine and 
taurine is indicative of hepatic necrosis. Creatine is 
synthesized and metabolized in the liver, with the 
kidney providing the necessary synthetic precursor. 
Guanidinoacetate, formed in the kidney, is transported 
through the blood, undergoing methylation in the liver 
to form creatine, which enters the blood for use in 
peripheral tissues [8]. Therefore, the observed 
increases in liver, kidney, plasma, and urine suggest 
leakage from necrotic cells or upregulated creatine 
biosynthesis. 
Damage to the proximal tubule is characterized by 
marked increases in the relative concentrations of 
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highly abundant metabolites in serum, due to a lack of 
reabsorption: glucose, lactate, alanine, and several 
other amino acids such as lysine, glutamine, glutamate, 
and valine. Glomerular toxicity hinders the filtration 
process and thus also produces the appearance of 
serum constituents in urine. Considerable increase of 
the concentration of amino acids (glycine and alanine) 
and glucose in the urine from VOSO4-treated rats 
indicated the decline of reabsorption ability of the renal 
tubule. The elevated urinary TMAO, DMG and DMA 
are the known markers of renal papillary lesion [9]. 
These findings implied the VOSO4-induced renal 
papillary lesion which was also confirmed by the 
alterations of biochemical parameters, the elevated 
creatinine level in serum. 
Table 1. Characteristic urinary metabolites of oral 
VOSO4 treatment in Wistar rats. 
VOSO4 dosed 
Metabolites NMR chemical shift or *loading region(s)a 
15mg/kg 45mg/kg 
lactate 1.33 (d) ↑ — 
alanine 1.48(d) ↑↑ ↑ 
acetate 1.93(s),4.08(q) ↓ ↓↓ 
succinate 2.42 (s,) ↓ ↓ 
glycoprotein 2.06 ↑ ↑↑ 
DMA 2.70 (s) ↑ ↑↑ 
DMG 2.98 (s) ↑ ↑ 
creatinine 4.05 (s), 3.05 (s) ↑ ↑↑ 
TMAO 3.26 (s) ↑ ↑↑ 
taurine 3.43 (t,), 3.26 (t) ↑ ↑↑ 
glycine 3.54 (s) ↑ ↑↑ 
glucose 3.5~4.0 ↑ ↑↑ 
urea 5.80(br) ↑ ↑↑ 
phenylalanine 7.35(m),7.42(m) — ↑ 
hippurate 7.73 (d), 7.64 (t), 7.55 (t) — ↑ 
Note. a Letters in parentheses indicate the peak multiplicities: s, 
singlet; d, doublet; t, triplet; q, quartet; m, complex multiplet; br, 
broad peak; “—“, the concentration is the same as the control; “↑” 
and “↓”, the amount is higher or lower; “↑↑” and “↓↓”, the amount is 
much higher or much lower respectively, compared with that of the 
control 
 
Decreases in acetate and an increase in lactate 
glycoprotein were evident in both low and high dose 
groups. These observations were suggestive of changes 
in carbohydrate and energy metabolism. This is 
supported by the progressive loss in body weight 
observed after dosing, likely to result from reduced 
feeding [10]. The different urinary excretion of 
hippurate, phenylalanine were also observed. These 
species are present in urine as products of intestinal 
microfloral metabolism. This implies that VOSO4 
affected the symbiotic gut microflora and the enzyme 
systems induced by diarrhea [11]. 
 
(a) PC1-PC2 score plot (■: control group;▼: 15 
mg/kg; : 45 mg/kg) 
 
(b)PC1-PC2 loading plot. 
Fig.2  PCA results of control and dosed group. 
 
3.2. Multivariable Statistical Analysis 
 
Principal components analysis (PCA) is a widely 
used dimension– reduction method, in which the NMR 
spectra can be reduced to a set of peak intensity 
descriptors, and used to detect toxicity and disease 
based on NMR biomarkers as well as identify 
similarities or differences between the samples from 
control and that from toxin-treated animals. 
The dose-dependent toxicity of VOSO4 was 
investigated by applying PCA to the data sets 
containing NMR spectra urine samples (Fig.2), The 
scores plots of the NMR spectra of urine samples 
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(Fig.2a) highlighted separation in the control group, 
low dose group and high dose group. This probably 
implied that the degree of energy metabolism 
disturbance dose induced by 15mg/kg body weight was 
different from that induced by 45mg/kg body weight. 
The loadings plot of the PCA result for urine samples 
(Fig.2b) shows those spectral regions that contribute 
the most to the separation of samples in scores plot. 
Based on the analysis of this plot, biomarkers could be 
identified. These included creatinine, taurine, TMAO, 
alanine, acetate, glycine, etc.. And hence, they may 
provide potential biomarkers for VOSO4 toxicity 
response. Further studies are in progress to identify 
these metabolites as VOSO4 toxicity biomarker. 
 
3.3. Biochemical characteristics and 
histopathology 
 
Compared to control group, the VOSO4-fed group 
showed external signs of toxicity after 3~5 day VOSO4 
administration, including diarrhea, decreased 
locomotor activity and general weakness. A significant 
decrease in weight gain was observed in both low dose 
group (15mg/kg body weight) and high dose group 
(45mg/kg body weight). These showed gastrointestinal 
toxic effects were main toxicity of VOSO4. VOSO4 
entered digestive tract and induced diarrhea by 
restraining involved enzymic activity and promoting 
gastrointestinal movement. Reduction in group mean 
body weight following dosing with VOSO4 may be 
mainly induced by diarrhea which resulted in serious 
dehydration. 
However, no substantial variations were observed in 
the biochemical parameter besides the elevation of 
creatine in VOSO4-fed group. Liver and kidney 
histopathology examinations were taken to check the 
changes in tissues. No microscopic abnormalities were 
observed in any of the animals killed after 16-day 
dosing (data not shown). These may imply VOSO4 
only induce slight alterations of liver and kidney 
function in clinical chemistry and histopathology. 
However, metabonomic approach may offer subtler 
information prior to conventional biochemical methods, 





NMR-based metabonomic has been used to assess 
toxicological effects of VOSO4. Significant changes of 
creatinine, taurine, TMAO, DMA, DMG, alanine, 
acetate, glycine and lactate indicated that VOSO4 
treatment affected energy metabolism process, 
interrupted intestinal microfloral metabolism, and 
induced liver, kidney injury. The greater magnitude of 
toxic response in the rat was highlighted in the 
metabolic trajectories of the scores from PCA of the 
urinary data. But no substantial variations were 
obtained in blood biochemical analysis and 
histopathological examination, which showed that 
NMR-based metabonomic can offer advantages to 
traditional clinical chemistry in the sensitivity and 
specificity of results obtained. And it is was proved to 
be of value in resolving the mechanistic complexity of 
drug toxicity as well as the benefits of frontloading this 
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